423 related articles for article (PubMed ID: 31699972)
1. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice.
Zheng C; Huang L; Luo W; Yu W; Hu X; Guan X; Cai Y; Zou C; Yin H; Xu Z; Liang G; Wang Y
Cell Death Dis; 2019 Nov; 10(11):848. PubMed ID: 31699972
[TBL] [Abstract][Full Text] [Related]
2. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
3. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice.
Zhang QY; Xu SJ; Qian JC; Yang LB; Chen PQ; Wang Y; Hu X; Zhang YL; Luo W; Liang G
Acta Pharmacol Sin; 2022 Feb; 43(2):354-366. PubMed ID: 34552217
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.
Xu Z; Zou C; Yu W; Xu S; Huang L; Khan Z; Wang J; Liang G; Wang Y
Br J Pharmacol; 2019 Jul; 176(14):2627-2641. PubMed ID: 30958891
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes.
Luo W; Huang L; Wang J; Zhuang F; Xu Z; Yin H; Qian Y; Liang G; Zheng C; Wang Y
J Endocrinol; 2019 Sep; 242(3):199-210. PubMed ID: 31277074
[TBL] [Abstract][Full Text] [Related]
8. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
9. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
10. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
11. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
12. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
13. Parkin ubiquitinates GATA4 and attenuates the GATA4/GAS1 signaling and detrimental effects on diabetic nephropathy.
Chen K; Chen J; Wang L; Yang J; Xiao F; Wang X; Yuan J; Wang L; He Y
FASEB J; 2020 Jul; 34(7):8858-8875. PubMed ID: 32436607
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy.
Luo W; Chen X; Ye L; Chen X; Jia W; Zhao Y; Samorodov AV; Zhang Y; Hu X; Zhuang F; Qian J; Zheng C; Liang G; Wang Y
J Ethnopharmacol; 2021 Mar; 268():113553. PubMed ID: 33152432
[TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
17. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.
Zhang X; He H; Liang D; Jiang Y; Liang W; Chi ZH; Ma J
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529235
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice.
Pontrelli P; Conserva F; Menghini R; Rossini M; Stasi A; Divella C; Casagrande V; Cinefra C; Barozzino M; Simone S; Pesce F; Castellano G; Stallone G; Gallone A; Giorgino F; Federici M; Gesualdo L
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068941
[TBL] [Abstract][Full Text] [Related]
20. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
